Nuvectis Pharma (NVCT) vs Obsidian Therapeutics (OBX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Obsidian Therapeutics is the larger company by market cap ($741.3 million vs $666.8 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NVCT | OBX |
|---|---|---|
| Share price | $19.39 | $12.00 |
| Market cap | $666.80M | $741.29M |
| 1-day change | -2.27% | -1.23% |
| YTD return | +156.82% | — |
| 1-year return | +218.91% | — |
| EPS (TTM) | $-2.00 | $-6.52 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Net income (latest FY) | $-26.44M | — |
| 52-week high | $29.28 | $49.97 |
| 52-week low | $5.77 | $9.60 |
| Distance from 52-week high | -33.77% | -75.99% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +82.57% | +222.25% |
| Average volume | 206.37K | 511.50K |
| Shares outstanding | 34.39M | 61.77M |
| Employees | 19 | 87 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Nuvectis Pharma
NVCT stock →Nuvectis Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology. The company is developing NXP900, a small molecule drug candidate, which is in Phase 1b clinical trial that inhibits the proto-oncogene c-Src and YES1 kinases for treating solid tumors.
Health Care · Biotechnology: Pharmaceutical Preparations · 19 employees
About Obsidian Therapeutics
OBX stock →Obsidian Therapeutics, Inc. operates as a clinical-stage biotechnology company developing engineered cell and gene therapies.
Health Care · Biotechnology: Pharmaceutical Preparations · 87 employees
NVCT vs OBX FAQ
Which is bigger, Nuvectis Pharma or Obsidian Therapeutics?
Obsidian Therapeutics (OBX) is larger, with a market capitalization of $741.29M compared with $666.80M for Nuvectis Pharma (NVCT).
Are Nuvectis Pharma and Obsidian Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.